Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 13.00M
March 31, 2026 17.03M
December 31, 2025 21.03M
September 30, 2025 10.70M
June 30, 2025 10.78M
March 31, 2025 13.28M
December 31, 2024 5.382M
September 30, 2024 5.39M
June 30, 2024 4.698M
March 31, 2024 6.475M
December 31, 2023 8.49M
September 30, 2023 8.457M
June 30, 2023 11.36M
March 31, 2023 9.085M
December 31, 2022 11.83M
September 30, 2022 14.53M
June 30, 2022 18.07M
March 31, 2022 20.51M
December 31, 2021 24.11M
September 30, 2021 26.58M
June 30, 2021 29.48M
March 31, 2021 32.74M
December 31, 2020 14.29M
September 30, 2020 16.92M
June 30, 2020 18.91M
Date Value
March 31, 2020 13.33M
December 31, 2019 6.984M
September 30, 2019 8.759M
June 30, 2019 10.87M
March 31, 2019 12.80M
December 31, 2018 14.93M
September 30, 2018 3.29M
June 30, 2018 5.365M
March 31, 2018 2.656M
December 31, 2017 3.631M
September 30, 2017 5.466M
June 30, 2017 7.752M
March 31, 2017 10.26M
December 31, 2016 12.96M
September 30, 2016 4.429M
June 30, 2016 5.882M
March 31, 2016 7.742M
December 31, 2015 10.67M
September 30, 2015 12.08M
June 30, 2015 14.04M
March 31, 2015 6.63M
December 31, 2014 8.546M
September 30, 2014 10.18M
June 30, 2014 11.96M
March 31, 2014 12.06M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Imunon, Inc. 6.864M
Agenus, Inc. 18.74M
Amgen, Inc. 13.99B
Anika Therapeutics, Inc. 38.41M
BioCryst Pharmaceuticals, Inc. 353.05M